Asking questions can cost your life in India - even if the right to solicit information is protected by law. Amar Nath Deo Pandey is luckier - in less than a week, he appears to have escaped two attempts on his life in a nondescript town in India's most populous state, Uttar Pradesh. More than five years after the introduction of a landmark law that allows Indians to access information held by...
More »SEARCH RESULT
Antibiotic challenges, dilemmas, policies by KS Jacob
India faces the challenge of inappropriate use of Antibiotics while Bharat copes with poor access to treatment, resulting in a policy conundrum and inaction. India was recently in the news for the wrong reasons. The serious threat posed by the newly discovered microbe, NDM-1 (New Delhi metallo--lactamase-1), resistant to many Antibiotics, triggered alarm and panic. Predictions that the country will not meet the millennium development goal for child mortality caused dismay....
More »Antibiotics may get costlier by Khomba Singh
The government may levy duty on two important drug ingredients imported from China and Mexico to protect local suppliers. The move could increase prices of popular Antibiotics for consumers besides threatening business of about two dozen small drugmakers. The commerce ministry has recommended anti-dumping duty on Penicillin G Potassium and 6 APA, after Indian suppliers complained Chinese and Mexican firms are shipping it at a low price to kill competition from...
More »A Light in India by David Bornstein
When we hear the word innovation, we often think of new technologies or silver bullet solutions — like hydrogen fuel cells or a cure for cancer. To be sure, breakthroughs are vital: Antibiotics and vaccines, for example, transformed global health. But as we’ve argued in Fixes, some of the greatest advances come from taking old ideas or technologies and making them accessible to millions of people who are underserved. One area...
More »Naming superbug after Delhi an ‘error’, Lancet says sorry by Teena Thacker
The editor of The Lancet, Richard Horton, has said naming a superbug after New Delhi was an “error”, and has apologised. Some Europeans returning from South Asia had been found infected with a bacteria carrying a drug-resistant gene last year, which had been named New Delhi metallo-beta-lactamase, or NDM-1, as the first patient had flown from Delhi to Sweden with the infection. While acknowledging this was a mistake, Horton said, “the science...
More »